secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001104659-25-058622
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics secures Nasdaq listing extension with transfer to Capital Market, strict conditions to Oct 7, 2025
--------------------------------------------------------------------------------

- Nasdaq Panel granted exception; listing transferred to Nasdaq Capital Market effective June 12, 2025.
- Must demonstrate closing bid price ≥$1.00 for 10 consecutive sessions by Oct 7, 2025.
- Must complete a strategic transaction and meet all initial listing requirements for Capital Market by Oct 7.
- Company had previously failed MVLS ($50M), MVPHS ($15M), and Bid Price ($1.00) rules.
- Panel may reconsider if conditions not met; no assurance of compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925058622/0001104659-25-058622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925058622/tm2517769d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer